Skip to Content

PRIMECAP Odyssey Stock POSKX

Medalist Rating as of | See PRIMECAP Investment Hub
  • NAV / 1-Day Return 38.54  /  +0.21 %
  • Total Assets 6.0 Bil
  • Adj. Expense Ratio
    0.670%
  • Expense Ratio 0.670%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 1.02%
  • Turnover 4%

USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:16 PM GMT+0

Morningstar’s Analysis POSKX

Will POSKX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still strong after a middling half-decade.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

With its outstanding investment team and unique multimanager approach, Primecap Odyssey Stock is exemplary within the large-blend Morningstar Category.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings POSKX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 36.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

9.01 521.7 Mil
Healthcare

AstraZeneca PLC ADR

3.87 224.2 Mil
Healthcare

Intel Corp

3.58 207.2 Mil
Technology

AECOM

3.47 200.9 Mil
Industrials

Dreyfus Treasury Secs Cash Mgmt Inst

3.28 189.8 Mil
Corporate

KLA Corp

2.99 172.9 Mil
Technology

Microsoft Corp

2.93 169.6 Mil
Technology

Amgen Inc

2.87 165.9 Mil
Healthcare

Siemens AG

2.79 161.8 Mil
Industrials

Biogen Inc

2.64 152.6 Mil
Healthcare